The Effects of Tryperygium Polyglycoside on Interleukin 6 and Its Soluble Receptor of Patients with Guillain-Barre Syndrome

王磊,袁锦楣,李静,郝洪军,牛俊英,金弘敏,冀成君
DOI: https://doi.org/10.3969/j.issn.1006-2963.2000.02.015
2000-01-01
Abstract:Objective To study the clinical effects of Trypergium polyglycoside (TII) in patients with Guillain- Barre syndrome (GBS)and its possible mechanism. Methods Interleukin 6 (IL-6),soluble interleukin 6 receptor(sIL-6R) were measured in cerebrospinal fluid (CSF) and serum of 43 patients and 48 controls with GBS using ELISA and double antibodies sandwich ELISA method. Results The level of IL-6 in serum and CSF in GBS group [serum:(69.73±25.25) ng/L, CSF:(14.33±6.69) ng/L] was higher than in normal control group [serum: (17.94±5.66) ng/L, CSF:(3.35±2.79)ng/L](t=13.16, 10.02; P<0.001), while the level of sIL-6R in serum and CSF of GBS group [serum:(46.65±11.59) μg/L, CSF:(9.45±0.98) μg/L] was also higher than in normal control group [serum: (29.25±11.04) μg/L, CSF:(1.38±0.50) μg/L] (t=7.33,48.48, P<0.001). There were positive correlation between CSF IL-6, sIL-6R and clinical severity (r=0.67, 0.48, P<0.01). After treatment with TII and corticosteroid the disease showed improved,as the level of CSF IL-6 and sIL-6R came down simultaneously. Moreover, a significant difference in CSF IL-6, sIL-6R of TII group and corticosteroid group (t=2.49, 2.26, P<0.05) was observed . Conclusion The level of CSF IL-6 and sIL-6R were a good index of severity and the TII was a useful drug in the treatment of GBS.
What problem does this paper attempt to address?